Abstract Human prion diseases are associated with a range of clinical presentations and are classified by both clinicopathological syndrome and aetiology with sub-
Introduction
Human prion diseases are invariably fatal conditions that include Creutzfeldt-Jakob disease (CJD), GerstmannSträussler-Scheinker disease (GSS), fatal familial insomnia (FFI), kuru and variant CJD (vCJD) in humans [28] . They are associated with a range of clinical presentations and are classified by both clinico-pathological syndrome and aetiology with sub-classification according to molecular criteria [28, 45, 54, 90, 121, 139] . These diseases have attracted immense research interest for many years not only because of their unique composition and properties but also because of their impact on public health [27, 30, 100, 129] . According to the widely accepted 'protein-only' hypothesis [47] , host-encoded cellular prion protein (PrP C ) is converted to an alternative form designated PrP Sc [22, 27, 30, 100, 129] . It is proposed that PrP Sc is the infectious agent acting to replicate itself with high fidelity by recruiting endogenous PrP C , and that the difference between these isoforms lies purely in the monomer conformation and its state of aggregation [22, 27, 30, 99, 100, 102, 107, 129] .
Central to understanding the molecular basis of prion propagation remains the conundrum of prion strains-how a protein-only infectious agent can encode information required to specify distinct disease phenotypes-and also the so-called species barrier effect which limits cross species infection. While originally considered different aspects of the prion problem, it is now clear that species barriers and prion strains are intimately related by ''conformational selection'' [26, 30] . Within the protein-only hypothesis of prion propagation prion strains are thought to be encoded by distinct pathogenic PrP conformations or assembly states. Conformational selection proposes that although a wide range of mammalian PrP Sc conformations may be possible, only a subset will be compatible with each individual PrP primary structure. Ease of transmission of prions between species (or also within species as a result of PrP polymorphisms), therefore, relates to overlap of permissible PrP
Sc conformations between the structures of PrP from the source and recipient as well as heterogeneity in cellular mechanisms affecting prion propagation and clearance kinetics [26, 30] . Conformational selection has now been strongly supported by elegant studies of prions in yeast and other fungi [14, 41, 62, 66, 106, 111, 112, 132] , and the wider relevance of prion-like mechanisms in other protein misfolding diseases is now becoming clear [30, 82, 85] . Understanding the molecular biology of prion disease will illuminate processes involving protein misfolding and aggregation and protein-based inheritance, which clearly have far-reaching implications in pathobiology, ageing and the evolution of cellular processes.
Aetiologies of human prion disease
Human prion diseases are biologically unique and can be divided aetiologically into inherited, sporadic and acquired forms [28] . Approximately 85% of human prion disease occurs sporadically as sporadic CJD at a rate of 1-2 cases per million population per year across the world, with an equal incidence in men and women [16, 27, 28, 38, 121] . Around 15% of human prion disease is associated with autosomal dominant pathogenic mutations in PRNP, and to date, over 30 mutations have been described [27, 28, 53, 65, 80, 121] . Acquired human prion diseases forms have, until recently, been confined to rare and unusual situations. Iatrogenic CJD has arisen as a result of transmission of CJD prions through treatment with pituitary hormones derived from human cadavers, implantation of dura mater grafts, corneal transplantation and the use of contaminated electroencephalographic electrodes [17, 18] 
Prion disease pathology and pathogenesis
The brains of patients with prion disease frequently show no recognisable abnormalities on gross examination at necropsy; however, microscopic examination typically reveals characteristic histopathologic changes, consisting of neuronal vacuolation and degeneration, which gives the cerebral grey matter a microvacuolated or 'spongiform' appearance, and a reactive proliferation of astroglial cells (for review see [19, 20] ). Although spongiform degeneration is frequently detected, it is not an obligatory neuropathologic feature of prion disease; the presence of astro-gliosis and micro-gliosis, although not specific to the prion diseases, is more constantly seen. The lack of a lymphocytic inflammatory response is also an important characteristic. Demonstration of abnormal PrP immunoreactivity, or more specifically biochemical detection of PrP Sc in brain material by immunoblotting techniques (Fig. 1) is diagnostic of prion disease, and some forms of prion disease are characterised by deposition of amyloid plaques composed of insoluble aggregates of PrP [19, 20] . Amyloid plaques are a notable (Fig. 2) . The histopathological features of vCJD are remarkably consistent and distinguish it from other human prion diseases with large numbers of PrP-positive amyloid plaques that differ in morphology from the plaques seen in kuru and GSS in that the surrounding tissue takes on a microvacuolated appearance, giving the plaques a florid appearance [59, 134] (Fig. 2) . Abundant florid plaques are established as the neuropathological hallmark of vCJD [59] and, to date, have only been found in association with BSE infection in hosts homozygous for PrP with methionine at residue 129 (in humans, primates or transgenic mice [6, 67, 119, 134] ).
Distinct forms of prion disease show differences in lymphoreticular involvement that appear to be related to the divergent properties of distinct prion strains [1] . For example, the tissue distribution of PrP Sc in vCJD differs strikingly from that in classical CJD and inherited prion disease [51-53, 55, 57, 61, 124] with uniform and prominent involvement of lymphoreticular tissues, with the highest amounts (up to 10% of brain concentrations) in tonsil [52, 124] . In contrast, in sporadic CJD, PrP Sc has only been irregularly detected by immunoblotting in noncentral nervous system tissues at very much lower levels [46, 94] . Tonsil biopsy is used for antemortem diagnosis of vCJD and, to date, has shown 100% sensitivity and specificity [52, 121, 124] , and tonsil is the tissue of choice for prospective studies investigating the prevalence of vCJD prion infection within the UK and other populations [24, 42, 56] . The fact that lymphoreticular prion infection is not a feature of iatrogenic CJD [51, 52] or kuru [15, 36] argues that the distinct pathogenesis of vCJD relates to the effect of prion strain rather than to a peripheral route of infection [15, 36, 127] . The demonstration of extensive peripheral tissue involvement in the pathogenesis of vCJD raises concern that asymptomatically infected carriers may be transmitting the disease to others via blood transfusion, as now appears to have occurred [71, 93, 136] , or other iatrogenic routes including contaminated surgical and medical instruments [4, 26, 120, 123] .
Determinants of phenotypic variability in human prion disease
The clinical presentation of human prion disease varies enormously, and there is considerable overlap observed between individuals with different disease aetiologies [28, 80, 120, 121] (Fig. 1 ) although much greater heterogeneity seems likely [121] . Sporadic and iatrogenic CJD and kuru are associated with PrP Sc types 1-3, while type 4 PrP Sc is uniquely associated with vCJD and is characterised by a fragment size and glycoform ratio that is similar to PrP Sc seen in BSE and BSE when transmitted to several other species [34, 54, 122, 127] . An earlier classification of PrP Sc types seen in classical CJD described only two banding patterns [88] with PrP Sc types 1 and 2 that we describe corresponding with the type 1 pattern of Gambetti and colleagues and our type 3 fragment size corresponding to their type 2 pattern [87, 90] . Consensus on the nomenclature of human PrP Sc types has been hindered by the fact that the N-terminal conformation of some PrP Sc subtypes seen in sporadic CJD can be interconverted in vitro via changes in metal-ion occupancy [54, 122] or solvent pH [21, 84, 138] . While it has proposed that pH alone determines the N-terminal structure of PrP Sc in sporadic CJD [21, 84] , this interpretation has not been supported by other studies [69, 98, 122] , and the conformations of PrP Sc types 1 and 2 that we describe in PRNP methionine homozygous patients show critical dependence upon the presence of copper or zinc ions under conditions, where pH 7.4 is tightly controlled [122] type that is preferentially propagated by its usual host) from which a less populous subspecies may be selected by an alternative host, resulting in a strain shift or mutation. In this regard, different cellular populations and tissues within a single host would provide different environments for strain selection as recently demonstrated in vitro [70] . Given the degree of molecular diversity observed in human prion disease, it may be extremely difficult to isolate the full complement of human prion strains in transgenic mice having a single genetic background.
Future perspectives
Despite major advances, the molecular basis of mammalian prion strain diversity remains unknown. To date, the conformational repertoire of pathological isoforms of wild-type human PrP and the various forms of mutant human PrP has not been fully defined. Biochemical investigation of diseaserelated PrP isoforms in patients allied with detailed clinical and neuropathological analysis will continue to inform on the diversity of phenotypes seen in human prion disease. As it has now become clear that prion strain type, host genetic makeup and numerous other factors may significantly influence prion disease phenotype, it is expected that the actual number of distinct human prion strains may be far less than the number of identified phenotypes. Detailed transgenic modelling will therefore be crucial to establishing how many human prion strains exist and what the defining molecular features of PrP are for each strain. This information allied with comprehensive transgenic modelling of human BSE infection and other relevant, potentially zoonotic, prion strains will inform on how many human prion strains may have an animal origin. Understanding the risks that existing and emerging animal prion diseases pose will have direct translation to protecting public health.
Development of an accurate classification for human prion disease will have major implications for epidemiological research into the causes of sporadic CJD, whose aetiology remains obscure. While spontaneous conversion of PrP C to PrP Sc as a rare stochastic event, or somatic mutation of the PrP gene, resulting in expression of a pathogenic PrP mutant are plausible explanations for sporadic CJD [16, 27, 78, 125] , other causes for at least some cases, include environmental exposure to human prions [37, 75, 95] or exposure to animal prions. In this regard, the number of prion strains causing sheep scrapie has yet to be established [8, 10, 12] , and epidemiological data cannot exclude this as a cause of a minority of cases. Similarities between types of sporadic CJD and types of sheep scrapie have been reported [130] . As future research begins to provide a more precise understanding of the origins of human prion disease, this will facilitate re-analysis of epidemiological data to reveal important risk factors that might have been obscured by analysing sporadic CJD as a single entity.
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